This
page
is
part
of
the
FHIR
Specification
(v5.0.0:
R5
-
STU
v6.0.0-ballot1:
Release
6
Ballot
(1st
Draft)
(see
Ballot
Notes
).
This
is
the
The
current
published
version
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
| Patient Care Work Group | Maturity Level : N/A | Standards Status : Informative | Compartments : No defined compartments |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile ConditionDefinition .
Generated Narrative: ConditionDefinition
Resource ConditionDefinition "example"
StructureDefinition Work Group : pc
url
:
http://hl7.org/fhir/ConditionDefinition/example
identifier
:
id: urn:oid:2.16.840.1.113883.4.642.25.1
id:
#
urn:oid:2.16.840.1.113883.4.642.25.1
name : Hyperlipidemia
title : Hyperlipidemia Status
status : draft
date : 2019-05-26T10:44:00+10:00
publisher : HL7 International / Patient Care
contact :
description : Hyperlipidemia Status
code : Hyperlipidemia (disorder) ( SNOMED CT #55822004)
hasSeverity : false
hasBodySite : false
hasStage : false
definition : https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf
observation
code
:
LDL
Chol.
(Calc)
(
LOINC
http://example.org/fhir/ObservationDefinition/lipid-panel
,
http://example.org/fhir/ObservationDefinition/cholesterol
,
http://example.org/fhir/ObservationDefinition/triglyceride
,
http://example.org/fhir/ObservationDefinition/cholesterol-hdl
,
http://example.org/fhir/ObservationDefinition/cholesterol-ldl
#13457-7
"Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
by
calculation")
| Code |
|
Gemfibrozil
(
RxNorm
|
| Reference |
| http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6 |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.